Costa, F., Vescovini, R., Bolzoni, M., Marchica, V., Storti, P., Toscani, D., . . . Giuliani, N. (2017). Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties. Oncotarget.
Chicago-tyylinen lähdeviittausCosta, Federica, et al. "Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Patients Targeting Monocyte Differentiation and Modulating Mesenchymal Stromal Cell Inhibitory Properties." Oncotarget 2017.
MLA-viiteCosta, Federica, et al. "Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Patients Targeting Monocyte Differentiation and Modulating Mesenchymal Stromal Cell Inhibitory Properties." Oncotarget 2017.